CAR-T Cell Therapy
Revolutionary immunotherapy that reprograms your own immune cells to fight cancer. China offers FDA-approved CAR-T treatments at 60-80% lower cost than the US.
Quick Answer
Revolutionary immunotherapy that reprograms your own immune cells to fight cancer. China offers FDA-approved CAR-T treatments at 60-80% lower cost than the US.
Need a clearer next step?
Get a free treatment-based case review before deciding where to seek care and which hospital path fits best.
How OriEast helps
We help international families compare treatment options, prepare records, and move smoothly from research to booking.
- ✓Review records and clarify whether this treatment is the right fit
- ✓Match the right hospital, department, and specialist pathway in China
- ✓Coordinate case evaluation and next-step booking plans
- ✓Support language, escort, and care navigation in Shanghai
Your records are only shared as needed to coordinate specialist review and booking.
Cost Comparison
* Prices are estimates and may vary based on individual cases. Contact us for a personalized quote.
Conditions We Treat
Treatment Process
Initial Consultation
3-5 daysSubmit medical records for review by our oncology team
Eligibility Assessment
1-2 weeksComprehensive evaluation to determine CAR-T candidacy
Cell Collection
1 dayLeukapheresis procedure to collect T-cells
CAR-T Manufacturing
2-4 weeksT-cells are engineered in the lab
Conditioning & Infusion
1 weekChemotherapy followed by CAR-T infusion
Monitoring
2-4 weeksClose observation for side effects
Partner Hospitals
Pubin Children's Hospital
Shanghai
Shanghai Sixth People's Hospital International Medical Center
Shanghai
Frequently Asked Questions
What is CAR-T cell therapy?
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a type of immunotherapy where your own T-cells are collected, genetically modified to recognize and attack cancer cells, then infused back into your body.
Why is CAR-T cheaper in China?
China has developed its own CAR-T products and manufacturing capabilities, reducing costs significantly. Lower labor costs, government subsidies for biotech, and competitive pricing among hospitals also contribute to savings.
Is CAR-T in China as effective as in the US?
Yes. Chinese CAR-T products have shown comparable efficacy rates in clinical trials. Several Chinese CAR-T therapies have received NMPA approval and are being used in international clinical trials.
What are the risks of CAR-T therapy?
Common side effects include Cytokine Release Syndrome (CRS) and neurological toxicity. Our partner hospitals have experienced teams and protocols to manage these complications effectively.
Ready to Explore Your Options?
Submit your medical records for a free, no-obligation evaluation. Our medical team will review your case and provide personalized recommendations.